Literature DB >> 25319958

Measuring chronic liver disease mortality using an expanded cause of death definition and medical records in Connecticut, 2004.

Kathleen N Ly1, Suzanne Speers2, R Monina Klevens1, Vaughn Barry1, Tara M Vogt1,3.   

Abstract

AIM: Chronic liver disease (CLD) is a leading cause of death and is defined based on a specific set of underlying cause-of-death codes on death certificates. This conventional approach to measuring CLD mortality underestimates the true mortality burden because it does not consider certain CLD conditions like viral hepatitis and hepatocellular carcinoma. We measured how much the conventional CLD mortality case definition will underestimate CLD mortality and described the distribution of CLD etiologies in Connecticut.
METHODS: We used 2004 Connecticut death certificates to estimate CLD mortality two ways. One way used the conventional definition and the other used an expanded definition that included more conditions suggestive of CLD. We compared the number of deaths identified using this expanded definition with the number identified using the conventional definition. Medical records were reviewed to confirm CLD deaths.
RESULTS: Connecticut had 29 314 registered deaths in 2004. Of these, 282 (1.0%) were CLD deaths identified by the conventional CLD definition while 616 (2.1%) were CLD deaths defined by the expanded definition. Medical record review confirmed that most deaths identified by the expanded definition were CLD-related (550/616); this suggested a 15.8 deaths/100 000 population mortality rate. Among deaths for which hepatitis B, hepatitis C and alcoholic liver disease were identified during medical record review, only 8.6%, 45.4% and 36.5%, respectively, had that specific cause-of-death code cited on the death certificate.
CONCLUSION: An expanded CLD mortality case definition that incorporates multiple causes of death and additional CLD-related conditions will better estimate CLD mortality. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  alcoholic liver disease; chronic liver disease mortality definition; hepatitis B; hepatitis C

Year:  2014        PMID: 25319958     DOI: 10.1111/hepr.12437

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

Review 1.  Cirrhosis-related musculoskeletal disease: radiological review.

Authors:  Ankur Arora; S Rajesh; Kalpana Bansal; Binit Sureka; Yashwant Patidar; Shalini Thapar; Amar Mukund
Journal:  Br J Radiol       Date:  2016-07-19       Impact factor: 3.039

2.  Estimating the Number of Patients Infected With Chronic HCV in the United States Who Meet Highest or High-Priority Treatment Criteria.

Authors:  Fujie Xu; Andrew J Leidner; Xin Tong; Scott D Holmberg
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

3.  Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019.

Authors:  Kathleen N Ly; Shaoman Yin; Philip R Spradling
Journal:  JAMA Netw Open       Date:  2022-06-01

4.  Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.

Authors:  Ming-Jen Sheu; Fu-Wen Liang; Ching-Yih Lin; Tsung-Hsueh Lu
Journal:  Popul Health Metr       Date:  2021-04-29

5.  Common musculoskeletal disorders in chronic liver disease patients.

Authors:  Rajat Ranjan; Sanjiv Rampal; Ashish Jaiman; Mehmet Ali Tokgöz; Jun Kit Koong; Kamarajan Ramayah; Ruveena Rajaram
Journal:  Jt Dis Relat Surg       Date:  2021-11-19

6.  Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals.

Authors:  Qianyu Guo; Jinfang Gao; Jiaoniu Duan; Ruihong Hou; Tsung-Hsueh Lu; Liyun Zhang
Journal:  Arthritis Res Ther       Date:  2022-02-12       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.